Xanthohumol is sensitive to TRAIL-induced apoptosis of LNCaP cancer cells; the expression of DR5 in LNCaP cells was upregulated after treatment with TRAIL and xanthohumol, promoting its programmed death. The gene discussed is TNFRSF10B; the disease is cancer.